PFM
Privium Fund Management Portfolio holdings
AUM
$464M
1-Year Return
124.83%
This Quarter Return
+10.91%
1 Year Return
+124.83%
3 Year Return
+508.69%
5 Year Return
–
10 Year Return
–
AUM
$392M
AUM Growth
+$17.6M
(+4.7%)
Cap. Flow
+$4.3M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
60.17%
Holding
139
New
22
Increased
37
Reduced
35
Closed
10
Top Buys
| 1 |
Tesla
TSLA
|
$9.79M |
| 2 |
Advanced Micro Devices
AMD
|
$4.78M |
| 3 |
ASTSW
AST SpaceMobile, Inc. Warrant
ASTSW
|
$3.71M |
| 4 |
ALX Oncology
ALXO
|
$2.27M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$1.5M |
Top Sells
| 1 |
Spotify
SPOT
|
$6.29M |
| 2 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$5.35M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$3.7M |
| 4 |
Protagonist Therapeutics
PTGX
|
$3.3M |
| 5 |
Moderna
MRNA
|
$1.94M |
Sector Composition
| 1 | Consumer Discretionary | 24.59% |
| 2 | Healthcare | 24.36% |
| 3 | Technology | 24.32% |
| 4 | Communication Services | 14.32% |
| 5 | Materials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coupang
CPNG
$52.3B
| $4.24M | 1.08% |
201,900
+5,000
| +3% | +$105K |
|
27
Zai Lab
ZLAB
$3.24B
| $3.75M | 0.96% |
215,789
-24,894
| -10% | -$432K |
|
|
ASTSW
28
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
| $3.71M | 0.95% |
+1,034,275
| New | +$3.71M |
|
|
29
Moderna
MRNA
$9.17B
| $2.72M | 0.69% |
23,261
-16,600
| -42% | -$1.94M |
|
30
uniQure
QURE
$939M
| $2.57M | 0.66% |
640,416
+61,501
| +11% | +$247K |
|
31
Acadia Pharmaceuticals
ACAD
$4.29B
| $2.35M | 0.6% |
148,400
| – | – |
|
|
32
ALX Oncology
ALXO
$56.8M
| $2.27M | 0.58% |
+396,966
| New | +$2.27M |
|
33
HEICO Class A
HEI.A
$35.3B
| $2.11M | 0.54% |
11,865
| – | – |
|
|
GRND.WS
34
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
| $2.03M | 0.52% |
701,118
+98,788
| +16% | +$286K |
|
|
CLBTW
35
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
| $1.81M | 0.46% |
643,948
-5,479
| -0.8% | -$15.4K |
|
|
SMR.WS
36
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
| $1.71M | 0.43% |
690,449
+243,476
| +54% | +$601K |
|
37
Biogen
BIIB
$20.3B
| $1.6M | 0.41% |
7,000
-160
| -2% | -$36.6K |
|
38
Under Armour
UAA
$2.2B
| $1.46M | 0.37% |
226,200
+3,300
| +1% | +$21.3K |
|
39
CRISPR Therapeutics
CRSP
$4.72B
| $1.45M | 0.37% |
27,347
+14,600
| +115% | +$776K |
|
40
Ambev
ABEV
$33.8B
| $1.31M | 0.33% |
635,914
+176,672
| +38% | +$364K |
|
41
Krystal Biotech
KRYS
$4.31B
| $1.14M | 0.29% |
6,420
+1,920
| +43% | +$341K |
|
42
Brown-Forman Class B
BF.B
$13.4B
| $1.1M | 0.28% |
25,800
| – | – |
|
43
Pfizer
PFE
$139B
| $1.01M | 0.26% |
36,120
+6,960
| +24% | +$194K |
|
44
Fox Class B
FOX
$24.6B
| $998K | 0.25% |
30,900
| – | – |
|
|
IMTXW
45
DELISTED
Immatics N.V. Warrants
IMTXW
| $902K | 0.23% |
295,814
+45,231
| +18% | +$138K |
|
46
Avidity Biosciences
RNA
$6.11B
| $863K | 0.22% |
22,242
+14,200
| +177% | +$551K |
|
47
4D Molecular Therapeutics
FDMT
$290M
| $823K | 0.21% |
40,000
+9,000
| +29% | +$185K |
|
48
Citigroup
C
$177B
| $807K | 0.21% |
12,478
-2,100
| -14% | -$136K |
|
49
MeiraGTx Holdings
MGTX
$586M
| $804K | 0.21% |
203,960
+83,975
| +70% | +$331K |
|
50
NOV
NOV
$4.83B
| $734K | 0.19% |
39,719
-4,900
| -11% | -$90.6K |
|